Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United StatesSang Kyu Cho, Scott Johnson, Suchin Virabhak et al.|PharmacoEconomics|2020Cited by 19